The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans

被引:97
作者
Choi, Su-Yeon [1 ]
Kim, Donghee [1 ]
Kim, Hwa Jung [2 ]
Kang, Jin Hwa [3 ]
Chung, Su Jin [1 ]
Park, Min Jung [1 ]
Kim, Young Sun [1 ]
Kim, Chung Hyun [1 ]
Choi, Seung Ho [1 ]
Kim, Won [4 ]
Kim, Yoon Jun [4 ]
Yoon, Jung-Hwan [4 ]
Lee, Hyo-Suk [4 ]
Cho, Sang-Heon [1 ]
Sung, Myung-Whun [1 ]
Oh, Byung-Hee [1 ]
机构
[1] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Inst Healthcare Res, Dept Internal Med, Seoul 135984, South Korea
[2] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 135984, South Korea
[3] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Inst Healthcare Res, Dept Radiol, Seoul 135984, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Liver Res Inst, Seoul 151, South Korea
关键词
ALANINE AMINOTRANSFERASE ACTIVITY; TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; HEPATIC STEATOSIS; CAROTID ATHEROSCLEROSIS; ADIPOSE-TISSUE; POPULATION; STEATOHEPATITIS; ASSOCIATION;
D O I
10.1038/ajg.2009.238
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is known to be related to factors that predict the development of coronary heart disease (CHD), such as dyslipidemia, central obesity, and metabolic syndrome (MS). The aim of this study was to determine whether individuals with NAFLD have an elevated risk of CHD, as estimated using the Framingham risk score (FRS). METHODS: A total of 21,130 individuals who underwent a voluntary general health examination were recruited. NAFLD was diagnosed among these individuals on the basis of typical sonographic findings and a level of alcohol consumption of <20 g/day. Of the 21,130 individuals, 3,780 were excluded because they had known causes of liver disease (1,690 were alcoholics, 975 had hepatitis B virus, 242 had hepatitis C virus, 91 had other hepatitis history, and 593 were taking medication known to produce fatty liver) or a history of heart disease (189). RESULTS: NAFLD was diagnosed in 5,769 of the 17,350 individuals (33.3%). The 11,581 normal individuals constituted the control group. The 5,769 individuals with NAFLD were split into two groups on the basis of ultrasonographic findings, that is, into a mild NAFLD group (n=3,278) and a moderate-severe NAFLD group (n=2,491). Individuals with NAFLD had an elevated risk of CHD, as estimated using FRS. Multivariable regression analysis, adjusted for confounding factors, showed a strong association between a higher FRS and NAFLD. CONCLUSIONS: Individuals with ultrasonographically detected NAFLD have an elevated 10-year risk of developing CHD as estimated using FRS. Furthermore, NAFLD was found to be independently related to the risk of developing CHD, regardless of classical risk factors and other components of MS.
引用
收藏
页码:1953 / 1960
页数:8
相关论文
共 45 条
[1]   Recent concepts in non-alcoholic fatty liver disease [J].
Adams, LA ;
Angulo, P .
DIABETIC MEDICINE, 2005, 22 (09) :1129-1133
[2]  
Bedogni Giorgio, 2004, Ann Hepatol, V3, P63
[3]   Nonalcoholic fatty liver disease is associated with carotid atherosclerosis -: A case-control study [J].
Brea, A ;
Mosquera, D ;
Martín, E ;
Arizti, A ;
Cordero, JL ;
Ros, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1045-1050
[4]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[5]   Ethnic differences of the presence and severity of coronary atherosclerosis [J].
Budoff, Matthew J. ;
Nasir, Khurram ;
Mao, Songshou ;
Tseng, Philip H. ;
Chau, Alex ;
Liu, Sandy T. ;
Flores, Ferdinand ;
Blumenthal, Roger S. .
ATHEROSCLEROSIS, 2006, 187 (02) :343-350
[6]  
Choi Su-Yeon, 2008, Korean J Hepatol, V14, P77, DOI 10.3350/kjhep.2008.14.1.77
[7]   Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies [J].
Clark, JM ;
Diehl, AM .
GASTROENTEROLOGY, 2003, 124 (01) :248-250
[8]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[9]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428
[10]   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].
Grundy, SM ;
Cleeman, JI ;
Merz, CNB ;
Brewer, HB ;
Clark, LT ;
Hunninghake, DB ;
Pasternak, RC ;
Smith, SC ;
Stone, NJ .
CIRCULATION, 2004, 110 (02) :227-239